Risk factor
Resilient to price shocks
Profitability factor
Greatly overvalued vs peers
About
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Target Price
The average target price of MED.SW is 101 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell